| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10039868 | HBV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS10050136 | HBV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20005760 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20042749 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014551 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014552 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014553 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014554 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014782 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
| TVIS20014795 | HPV | ENSG00000165029.17 | protein_coding | ABCA1 | No | No | 19 | B2RUU2 B7XCW9 O95477 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ABCA1 |
|---|---|
| DrugBank ID | DB00171 |
| Drug Name | ATP |
| Target ID | BE0000119 |
| UniProt ID | O95477 |
| Regulation Type | |
| PubMed IDs | 17135600; 17224860; 16858612 |
| Citations | Porchay I, Pean F, Bellili N, Royer B, Cogneau J, Chesnier MC, Caradec A, Tichet J, Balkau B, Marre M, Fumeron F: ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study. Obesity (Silver Spring). 2006 Nov;14(11):1874-9.@@Badeau R, Jauhiainen M, Metso J, Nikander E, Tikkanen MJ, Ylikorkala O, Mikkola TS: Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women. Menopause. 2007 Mar-Apr;14(2):293-9.@@Zarubica A, Trompier D, Chimini G: ABCA1, from pathology to membrane function. Pflugers Arch. 2007 Feb;453(5):569-79. Epub 2006 Jul 21. |
| Groups | Investigational; Nutraceutical |
| Direct Classification | Purine ribonucleoside triphosphates |
| SMILES | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O |
| Pathways | Glycerolipid Metabolism; Fatty Acid Metabolism; Pamidronate Action Pathway; Simvastatin Action Pathway; Citric Acid Cycle; Glutamate Metabolism; Argininosuccinic Aciduria; Gluconeogenesis; Betaine Metabolism; Butyrate Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Rosuvastatin Action Pathway; Propanoate Metabolism; Pentose Phosphate Pathway; Pyruvate Metabolism; Inositol Metabolism; Zoledronate Action Pathway; Glycine and Serine Metabolism; Selenoamino Acid Metabolism; Thiamine Metabolism; Pyrimidine Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Ammonia Recycling; Histidine Metabolism; Pravastatin Action Pathway; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Purine Metabolism; Fluvastatin Action Pathway; Galactose Metabolism |
| PharmGKB | PA164743471 |
| ChEMBL | CHEMBL14249 |
